These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Quality control and good manufacturing practices: safety and efficacy of commercial herbals. Awang DV Food Drug Law J; 1997; 52(3):341-4. PubMed ID: 10343036 [No Abstract] [Full Text] [Related]
9. Reaction of FDA to a fundamental change in the nature of regulations. Kennedy D J Parenter Drug Assoc; 1979; 33(1):17-20. PubMed ID: 253023 [No Abstract] [Full Text] [Related]
10. Responsible extra-label use of drugs. Cobb DV J Am Vet Med Assoc; 1996 Nov; 209(9):1545. PubMed ID: 8899012 [No Abstract] [Full Text] [Related]
11. The use of consultants in the parenteral industry. Agalloco JP J Parenter Sci Technol; 1986; 40(6):277-83. PubMed ID: 3819981 [No Abstract] [Full Text] [Related]
12. FDA's role in drug product recalls. Crawford SY Am J Hosp Pharm; 1991 Dec; 48(12):2595-6. PubMed ID: 1814194 [No Abstract] [Full Text] [Related]
13. Toward more effective drug regulation. Schmidt AM FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532 [No Abstract] [Full Text] [Related]
14. Regulatory requirements with regard to the use of investigational new drugs. Hodges RM Antimicrob Agents Chemother (Bethesda); 1967; 7():16-8. PubMed ID: 5631922 [No Abstract] [Full Text] [Related]
15. Comments about vitamins, nutraceuticals, and dietary enzymes. Henderson TR J Am Vet Med Assoc; 1995 Jul; 207(1):31. PubMed ID: 7601686 [No Abstract] [Full Text] [Related]
16. Separate manufacturing standards needed for veterinary drugs: AVMA. J Am Vet Med Assoc; 1996 Feb; 208(4):461. PubMed ID: 8603886 [No Abstract] [Full Text] [Related]
17. FDA takes action against firms in scandal over generic products. Pollner F Med World News; 1989 Sep; 30(17):14-5. PubMed ID: 10294736 [No Abstract] [Full Text] [Related]